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Hematopoietic progenitors have been shown to retain plasticity and switch lineages by appropriate
stimuli. However, mature blood cells hardly showed such differentiation plasticity. In this paper, we
tried to reprogram mature B cells into erythroid lineage by expressing various hematopoietic tran-
scription factors. Among various factors, GATA-1, SCL together with CCAAT/enhancer binding protein
(C/EBP) a turned out to be a minimal set of factors that efﬁciently reprogrammed terminally differ-
entiated mature B cells into erythroid lineage, as evidenced by colony forming assays and erythroid-
speciﬁc gene expressions. This study sets an avenue to generate autologous erythrocytes from
peripheral B cells.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Differentiation of hematopoietic cells is a sequential process of
cell fate decision dictated by the lineage-speciﬁc transcription fac-
tors. For example, differentiation of granulocyte monocyte progen-
itors (GMPs) from common myeloid progenitors (CMPs) critically
depends on the expression of CCAAT/enhancer binding protein
(C/EBP) a [1,2]. On the other hand, GATA-1 is critical for the devel-
opment of megakaryocytes and erythroid cells [3–5]. These line-
age-speciﬁc transcription factors possess strong lineage
instructing capacities by activating gene expression programs spe-
ciﬁc to the respective lineage.
It is now widely accepted that hematopoietic progenitors retain
developmental plasticity and they can be reprogrammed by appro-
priate lineage-converting stimuli. It was reported that common
lymphoid progenitors (CLPs) and pro-T cells could be converted
into granulocyte/monocyte (GM) lineage by enforced cytokine sig-
nals, suggesting that immature lymphoid cells retain latent mye-
loid differentiation potential [6]. It was subsequently shown that
ectopic expression of lineage speciﬁc transcription factors such as
GATA-1 or C/EBPa could redirect immature hematopoietic progen-
itors to erythroid/megakaryocytic or myelomonocytic lineage,
respectively [7–9]. We have also shown that conditional activation
of C/EBPa could reprogram CLPs, megakaryocyte/erythroid progen-chemical Societies. Published by E
ology, Department of Internal
Shinanomachi, Shinjuku-ku,
).itors (MEPs), and immature B and T cells into GM lineage [10].
These data suggest that overexpression of lineage-speciﬁc tran-
scription factors can override the lineage commitment program
and induce lineage switch. Moreover, further studies revealed that
C/EBPa could reprogram terminally differentiated mature B cells
into myeloid cells [8]. However, mature lymphocytes have never
been reprogrammed into erythroid lineage.
Somatic cell reprogramming into induced pluripotent stem cells
(iPSCs) is a strikingly powerful way to obtain a patient-speciﬁc cell
source for regenerative medicine, and differentiation protocols for
iPSCs to various tissue-speciﬁc cells are now under active investi-
gation. In hematopoietic system, induction of mature blood cells
such as erythrocytes or platelets from iPSCs is an attracting possi-
bility to obtain autologous blood cells for transfusion. However,
induction of mature blood cells from iPSCs generally requires elab-
orative culture process, and implies a risk of teratoma formation by
contaminated undifferentiated iPSCs when they are applied to pa-
tients. Therefore, direct reprogramming is considered to be more
feasible and practical way for obtaining speciﬁc type of tissue cells
for clinical application compared to using iPSCs or embryonic stem
cells (ESCs).
In this study, we attempted to reprogram terminally differenti-
ated mature B cells into erythroid lineage, and to deﬁne minimal
set of transcription factors required for erythroid reprogramming.
We found that the combination of GATA-1, SCL and C/EBPa was
sufﬁcient to reprogram mature B cells into erythroid lineage. This
is the ﬁrst report to demonstrate the reprogramming of mature B
cells into erythroid lineage and opens up an avenue to generate
autologous erythrocytes from easily obtainable, peripheral B cells.lsevier B.V. All rights reserved.
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2.1. Mice
C57BL6/J (Ly5.2) mice were from Japan CLEA Inc. (Tokyo, Japan).
C/EBPa-ER transgenic (Tg) mice were described previously [10].
Mice from 8 to 12 weeks old were used in all experiments. All mice
were bred and maintained in speciﬁc pathogen-free environment,
and all animal experiments were carried out according to the
guidelines for animal use issued by the Committee of Animal
Experiments, Keio University School of Medicine.
2.2. Reagents
4-Hydroxytamoxifen (4-HT, Sigma–Aldrich) was dissolved in
ethanol (EtOH) at 5 mM and was used at the ﬁnal concentration
of 1 lM. All cytokines were purchased from R&D Systems.
2.3. Antibodies
The following monoclonal antibodies were used for ﬂow cyto-
metric analysis: FITC-anti-B220 (Biolegend), PE-anti-CD19 (BD
Pharmingen), FITC-anti-CD45.2, PE-anti-CD45, PE-anti-CD3 (eBio-
science), FITC-anti-Gr1, and PE-anti-CD11b (BD Biosciences).
2.4. Plasmids
Retrovirus vector expressing full-length murine GATA-1
fused to the mutated ligand-binding domain of the mouse estrogen
receptor (pMXs-IRES-GFP (IG)/GATA-1-ER) and pMSCV-GFP/
GATA-2 is a generous gift from Dr. Ezoe, Osaka University. pMXs-
IG/GATA-1 was from Dr. Nakano, Osaka University. pMYs-IG/Hes-
1, pMYs-IG/SCL and pGCDNSan-IG/Evi-1 are generous gifts from
Dr. Kurokawa, University of Tokyo. pMY-IG/C/EBPa-ER was
described previously [10].
2.5. Production of retrovius
Retrovirus plasmids were transiently transfected into PLAT-gp
cells using Fugene 6 (Roche Diagnostics) according to the manufac-
turer’s protocol. Medium was changed 24 h after transfection, and
supernatants containing retrovirus were collected after another
24 h. To make stable retroviral producer lines, PLAT-E cells were
infected in the presence of 10 lg/ml polybrene (Sigma–Aldrich)
with retrovirus produced by PLAT-gp cells, and 2–3 days later,
GFPhigh PLAT-E cells were sorted using MoFlow cytometer (Beck-
man Coulter). Sorted PLAT-E cells were expanded in the culture,
and their culture supernatant was used as high-titer retroviral
supernatants.
2.6. Isolation and retroviral transduction of murine mature B cells
Spleen cells were obtained from C57BL6/J (Ly5.2) mice or C/
EBPa-ER Tg mice, and mononuclear cells were separated by den-
sity-gradient centrifugation using Lymphoprep (Axis-Shield PoC
AS). Mature B cells were enriched by magnetic cell sorting using
MACS B cell Isolation Kit (Miltenyi Biotec) according to the manu-
facturer’s protocol. Isolated B cells were stained with anti-B220-
FITC and anti-CD19-PE antibodies, and analyzed by FACS Caliber
(BD bioscience) for their purity. The purity of B cells was more than
95% in all experiments.
Puriﬁed B cells were stimulated in Iscove’s Modiﬁed Dulbecco’s
Medium (IMDM; Invitrogen, Carlsbad, CA) supplemented with 10%
FBS, 100 U/ml penicillin G, 100 lg/ml streptomycin, 50 lM 2-
mercaptoethanol, 10 lg/ml Lipopolysaccharide (LPS; Sigma–
Aldrich), 0.1 lg/ml anti-CD40 (BD Biosciences) and 10 ng/ml IL-4(Peprotech). Retrovirus infection was performed using Retronectin
(Takara Bio) according to the manufacturer’s protocol.
2.7. Colony assay
B cells infected with retrovirus (1  105 cells/dish) were cul-
tured in MethoCult GF M3434 (Stem Cell Technologies) supple-
mented with 10 ng/ml of human (h) thrombopoietin (TPO),
10 ng/ml of mouse (m) granulocyte macrophage-colony stimulat-
ing factor (GM-CSF), with or without 1 lM 4-HT. After 7–10 days
of culture, number of colonies was enumerated under an inverted
microscope. For the morphological examinations, colonies were
picked, cytospun onto glass slides, and stained by Wright–Giemsa
staining. Fluorescent images were examined and captured by laser
confocal microscope (Olympus).
2.8. Extraction of DNA and RNA
Extraction of genomic DNA was performed using DNeasy Blood
& Tissue Kit (Qiagen). Total RNA was extracted using Trizol reagent
(Invitrogen), and then treated with RNase-free DNase I (Invitrogen)
to remove contaminating genomic DNA. Messenger RNA (mRNA)
was isolated using Micro-FastTrack 2.0™ mRNA Isolation Kit
(Invitrogen).
2.9. PCR analysis
PCR analyses for rearrangements of immunoglobulin heavy
chain genes were carried out as previously described [8] using Ex
Taq-HS polymerase (TaKaRa). To examine the integration of trans-
duced genes, PCRwas performed using the primer sets listed in Sup-
plementary Table 1. For RT-PCR, cDNA was synthesized with Super
Script II reverse transcriptase (Invitrogen), and PCR was performed
using Ex Taq-HS polymerase (TaKaRa). Primer sequences for line-
age-speciﬁc genes and GAPDH were described previously [7].3. Results
3.1. Mature B cells can be reprogrammed into erythroid-like cells by
co-introduction of various transcription factors
To reprogram B cells into erythroid lineage, we tried to express
transcription factors related to erythroid differentiation such as
GATA-1 and SCL. In addition, we used transcription factors ex-
pressed in immature hematopoietic cells such as GATA-2, Hes-1
and Evi-1, hoping that they facilitate the reprogramming process
(Fig. 1A). Of note, GATA-2 is highly expressed not only in immature
hematopoietic cells, but also in MEPs [7], suggesting that it may be
useful for erythroid conversion. Previous study has shown that C/
EBPa is required for efﬁcient reprogramming of mature B cells
[11], and therefore we decided to include C/EBPa in reprogram-
ming factors. For activating C/EBPa in B cells, we employed trans-
genic mice expressing conditional form of C/EBPa (C/EBPa-ER Tg)
whose activity can be induced by 4-hydroxy tamoxifen (4-HT)
[10]. We have also used inducible form of GATA-1 (GATA-1-ER)
for the experiments. As noted in the discussion, however, weak
activity of C/EBPa-ER or GATA-1-ER leaking under the non-induced
condition was sufﬁcient to induce erythroid conversion of B cells,
and reprogramming efﬁciency as well as the phenotype of repro-
grammed cells was not different between induced- and non-in-
duced states. For this reason, we hereafter do not speciﬁcally
mention the supplemental status of 4-HT unless otherwise
required.
We puriﬁed splenic B cells from C/EBPa-ER Tg mice, and stim-
ulated them with anti-CD40 and LPS. Activated B cells with over
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C
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Fig. 1. Reprogrammingof B cells from C/EBPa-ER Tg or WT mice into erythroid-like cells. (A) Schematic illustration of retrovirus transduction to B lymphocytes from C/EBPa-
ER Tg mice and colony assay. (B) Purity of mature B cells used for retrovirus transduction. Expression of B220 and CD19 was assessed by ﬂow cytometry. (C) Representative
erythroid-like colonies on day 7–10 of cultures (upper panel. Original magniﬁcation: 20X) and the morphology of erythroid cells by cytospin preparation (lower panel.
Wright-Giemsa staining. Original magniﬁcation: 400X). Numbers of erythroid-like (erythroid) and myeloid (GM) colonies generated are shown on the right (mean ± S.D.,
n = 3). (D) PCR analysis for integration of transduced genes. Sample numbers that correspond to those in (C) are shown on each lane. The primer sets used for PCR analysis are
shown in Supplementary Table 1. P; positive control. (E) Rearrangements of IgH gene in erythroid-like colony converted from B cells. Polyclonal splenic B cells from C57BL6/J
mice were used as a control (left). Representative results from the converted erythroid-like colony are shown on the middle and the right. A, B, C, D, E, F, G, DQ52, DFS,JH4A
stand for the name of the primers set in the exons of VH, DH or JH region of IgH gene as previously described [8]. Position of each primer is schematically presented at the
bottom. Neg; negative control. (F) Reprogramming of wild-type B cells into erythroid lineage. Transduced genes are shown on the list on the upper panel. Morphologies of
representative erythroid-like colonies formed in the presence or absence of 4HT are shown on the lower panel. Numbers of erythroid-like (erythroid) and myeloid (GM)
colonies generated by this protocol are shown on the lower-right (mean ± S.D., n = 6).
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by retrovirus, and differentiation capacity of infected cells was as-
sessed by colony assays. After 7-days of culture, erythroid-like col-
onies highly similar to burst forming unit-erythroid (BFU-E)
showed up in culture plates (Fig. 1C). Examination of cellular mor-
phology by cytospin preparation conﬁrmed that the cells isolated
from the colonies presented erythroid morphology (Fig. 1C). We
picked up individual colonies and examined the integration of
transduced genes by PCR (Fig. 1D). Of three colonies examined,
GATA-1-ER was commonly integrated in all three clones, whereas
SCL was integrated in two clones. One clone retained Hes-1 and
Evi-1 transgenes in addition to GATA-1-ER and SCL. To check
whether these erythroid-like colonies were converted from B cells,
we examined the rearrangement of immunoglobulin heavy chain
(IgH) genes by genomic PCR. As shown in Fig. 1E, rearrangement
of IgH gene could be detected in the cells from the erythroid-like
colony, showing that they originated from B cells. It is of note that
all erythroid-like colonies were positive for GFP (data not shown),
and mock-infected B cells formed very few erythroid colonies (Sup-
plementary Table 2), suggesting that erythroid-like colonies were
not derived from the contaminated erythroid precursors.We have also tried reprogramming of splenic B cells from wild-
type (WT) mice instead of C/EBPa-ER Tg mice by transducing the
same set of transcription factors together with C/EBPa-ER using
retrovirus (Fig. 1F). As expected, conversion of B cells into ery-
throid-like colonies could be achieved by this combination of fac-
tors either with or without 4HT.
These data suggest that terminally differentiated B cells can be
reprogrammed into erythroid lineage by introducing GATA-1-ER,
SCL, Hes-1 and Evi-1 combined with the activation of C/EBPa.
The requirement of GATA-2 was not apparent since integration of
GATA-2 was not detected in erythroid-like colonies by PCR. It is
of note that C/EBPa is not absolutely essential for reprogramming
process, since B cells could be converted into erythroid-like cells
without C/EBPa activation (Supplementary Fig. 1).
3.2. GATA-1 in combination with SCL is sufﬁcient for efﬁcient
reprogramming of B cells and C/EBPa facilitates the reprogramming
Analysis of integrated genes revealed that GATA-1-ER and SCL
were commonly integrated in most of the erythroid-like colonies
converted from B cells (Supplementary Table 3). Based on this ﬁnd-
AB
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Fig. 2. Erythroid conversion of B cells by GATA1, SCL and C/EBPa. (A) Schematic illustration of retrovirus transduction to B lymphocytes from C/EBPa Tg or WT mice and
colony assay. (B) Pictures of erythroid-like colonies converted by GATA-1-ER, GATA-1-ER + SCL, GATA-1-ER + C/EBPa, or GATA-1-ER + SCL + C/EBPa. (C) Numbers of erythroid-
like colonies converted by various combinations of GATA1, SCL and C/EBPa (mean ± S.D., n = 3).
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throid conversion. We tried to conﬁrm this assumption by trans-
ducing GATA-1-ER or SCL separately or in combination into
mature B cells from WT or C/EBPa-ER Tg mice (Fig. 2A). As shown
in Fig. 2B and C, GATA-1-ER in combination with SCL efﬁciently
converted mature B cells as compared to GATA-1-ER or SCL alone.
Furthermore, co-expression of C/EBPawith GATA-1-ER and SCL en-
hanced the conversion efﬁciency approximately by twofold. These
results suggest that GATA-1-ER plus SCL is sufﬁcient to reprogram
mature B cells into erythroid-like cells and co-expression of C/EBPa
signiﬁcantly facilitates this process.
To check whether GATA-1-ER truly mimics wild-type GATA-1,
we have tried using non-inducible form of GATA-1 in the same set-tings, and conﬁrmed that GATA-1 in combination with SCL was in-
deed sufﬁcient for efﬁcient reprogramming of mature B cells into
erythroid lineage (Supplementary Table 4).
3.3. Gene expression of erythroid-like cells reprogrammed from B cells
We next investigated whether erythroid-like cells repro-
grammed from B cells recapitulates bone a ﬁde erythroid cells
not only phenotypically but also molecularly by examining the
pattern of gene expression (Fig. 3A, B and C). RT-PCR analysis re-
vealed that reprogrammed erythroid-like colonies expressed
erythrocyte-speciﬁc genes such as erythropoietin receptor (EpoR),
FOG-1, and b-globin, whereas myeloid-speciﬁc genes such as gran-
AB
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Fig. 3. Gene expression pattern of reprogrammed erythroid-like cells. (A) Morphology of representative erythroid-like colony produced from C/EBPa-ER Tg B cells by GATA-
1-ER and SCL. Fluorescent image captured by ﬂuorescent microscopy is shown on the right. (B) RT-PCR analysis for various lineage-speciﬁc genes expressed in a
representative erythroid-like colony and a control GM colony. E: erythroid colony, GM: GM colony. (C) Summary of the result from RT-PCR analysis shown in (B).
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colony stimulating factor receptor (M-CSF R), and granulocyte
macrophage-colony stimulating factor receptor (GM-CSF R) were
not expressed. Interestingly, PU.1, a transcription factor mainly ex-
pressed in early B and myeloid cells, was expressed in repro-
grammed cells, while B-cell speciﬁc transcription factor Pax5 was
not. As a control, we examined a GM colony emerged from B cells
by different set of transcription factors. This clone expressed mye-
loid genes such as G-CSF R, M-CSF R, GM-CSF R, c-Kit and PU.1,
whereas erythroid genes were not expressed. These results clearlyshow that erythroid-like cells reprogrammed from terminally dif-
ferentiated B cells demonstrate erythroid-speciﬁc pattern of gene
expression, suggesting that erythroid conversion was achieved
not only phenotypically, but also at molecular levels.4. Discussion
Generation of iPSCs from somatic cells by deﬁned factors has
enabled us to make pluripotent cells genetically identical to an
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ideal cell source for regenerative medicine, but also they are useful
for studying tissue development and cellular differentiation, drug
development, or modeling diseases. One of the major interests in
the ﬁeld of hematology has been the induction of mature hemato-
poietic cells such as red blood cells (RBCs) and platelets from iPSCs
or ESCs. In fact, several investigators reported generation of RBCs
or platelets in vitro from iPSCs or ESCs [12–17]. However, there
are a number of problems that preclude application of induced
cells or tissues from pluripotent cells. These include; (1) teratoma
formation from residual undifferentiated iPSCs or ESCs when they
are applied to patients, (2) time and efforts to generate iPSCs from
the patients and to induce their differentiation. Direct reprogram-
ming of somatic cells into another is an alternative, feasible ap-
proach for obtaining speciﬁc type of tissue cells [18]. By this
strategy, several groups have reported successful generation of
dopaminergic or glutamatergic neurons, cardiomyocytes, hepato-
cytes, blood progenitors from ﬁbroblasts and b-cells from pancre-
atic exocrine cells [18]. These technologies are advantageous over
pluripotent cells in that they theoretically have no risk of teratoma
formation and they offer quicker ways to get the differentiated
cells.
Within hematopoietic system, direct conversion of hematopoi-
etic progenitors has been achieved by ectopic expression of line-
age-speciﬁc transcription factors. We have previously shown that
myeloid speciﬁc transcription factor C/EBPa could convert com-
mon lymphoid progenitors (CLPs) and megakaryocyte erythroid
progenitors (MEPs) into myeloid lineage by using transgenic
mouse model expressing inducible form of C/EBPa [9,10], and oth-
ers have presented reprogramming of B and T cell progenitors into
macrophages by C/EBPa [8,9]. It was also reported that GATA-1
could convert myeloid precursors and CLPs into erythroid lineage
[7]. Such differentiation plasticity is not limited to hematopoietic
progenitors, and in fact, some of the terminally differentiated cells
that were thought to have lost differentiation plasticity were pro-
ven vulnerable to lineage converting stimuli. For example, ectopic
expression of C/EBPa or PU.1 could convert terminally differenti-
ated mature B cells into myeloid cells [8]. However, it is not clear
whether mature lymphocytes could be reprogrammed into ery-
throid lineage or not.
In this paper, we tried to reprogram terminally differentiated
mature B cells into erythroid lineage and identify factors sufﬁcient
for the reprogramming. In light of the previous report of GATA-1-
mediated erythroid conversion, we assumed that GATA-1 would
be the key factor to reprogram mature B cells as well. As expected,
GATA-1 was essential for erythroid reprogramming of mature B
cells. Interestingly however, efﬁcient reprogramming of mature B
cells required SCL and C/EBPa, whereas GATA-1 alone was sufﬁ-
cient for that of progenitors such as CLP and GMP. One of the rea-
sons for this discrepancy may be the different degrees of
differentiation plasticity that the cells inherently possess. In con-
trast to CLPs or pro-B cells, terminally differentiated mature B cells
are relatively resistant to reprogramming, and their commitment
to B-lineage must be unﬁxed by inactivation of Pax5, a critical tran-
scription factor for B cell differentiation, for reprogramming [11].
C/EBPa was shown to suppress transcriptional activity of Pax5
and to serve as a reprogramming factor of B cells [8]. We therefore
utilized C/EBPa-ER Tg mice that we previously developed in which
C/EBPa can be activated conditionally by 4-HT. Our data indicated
that the activation of C/EBPa indeed enhanced the reprogramming
efﬁciency by twofold, showing that C/EBPa can serve as a facilita-
tor of reprogramming in our system.
SCL is a member of basic helix-loop-helix (bHLH) type tran-
scription factors, whose expression is restricted to immature
hematopoietic cells and erythroid/megakaryocytic lineage in adult
hematopoiesis [19,20]. An essential function of SCL in hematopoi-etic development such as the speciﬁcation of primitive and deﬁn-
itive hematopoiesis was also noted by gene-knockout studies
[21]. With regard to erythroid/megakaryocytic differentiation, it
was reported that SCL plays an essential role in megakaryocyte
and erythroid-speciﬁc gene expression programs [22]. In erythroid
cells, SCL forms a multiprotein complex containing GATA-1 and
their coregulators Lmo2 and Ldb1 [23,24]. This complex binds to
the DNA element containing sequentially aligned E-box and GATA
site, which is frequently found in the promoters of erythroid-spe-
ciﬁc genes such as EKLF [24,25]. These observations strongly sug-
gest that GATA-1 and SCL cooperatively regulate erythroid
differentiation. On the other hand, SCL regulates the expression
of c-kit, a receptor for stem cell factor (SCF) [26], and SCF together
with erythropoietin regulates erythroid differentiation in non-
redundant fashion [27]. Taken all together, these observations
clearly show a critical role of SCL in erythroid differentiation, pro-
viding a molecular basis for its synergy with GATA-1 to reprogram
B cells into erythroid lineage.
We used inducible forms of C/EBPa and GATA-1 (C/EBPa-ER and
GATA-1-ER, respectively) for reprogramming in an attempt to have
non-inducible state serve as a negative control. Unexpectedly,
however, conversion of B cells into erythroid lineage occurred in
a similar frequency in either induced- or non-induced-state. It
should be noted that C/EBPa-ER and GATA-1-ER proteins were
considered to be functionally expressed, since the reprogramming
efﬁciency clearly decreased without either of these factors. These
results imply that the weak activities of C/EBPa or GATA-1 leaking
under the non-induced state must be sufﬁcient to help convert B
cells into the erythroid lineage. It is of note that non-inducible
form of GATA-1 in combination with SCL was sufﬁcient for efﬁcient
reprogramming of mature B cells into erythroid lineage, conﬁrm-
ing thatGATA-1-ER truly mimics wild-type GATA-1.
In summary, we showed that the combination of GATA-1, SCL
and C/EBPa could directly convert terminally differentiated mature
B cells into erythroid lineage. Since mature B cells can be obtained
easily from peripheral blood, this study would be a valuable one-
step forward in generating autologous erythrocytes by direct
reprogramming.
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